Skip to main content

and
  1. Article

    Open Access

    A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer

    Many emerging new drugs have recently been trialled for treatment of early and advanced breast cancer. Among these new agents paclitaxel and gemcitabine play a crucial role, mostly in patients with relapsed an...

    Silverio Tomao, Adriana Romiti, Federica Tomao, Marisa Di Seri in BMC Cancer (2006)

  2. Article

    Open Access

    Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features

    Extraneural metastases (ENM) rarely occur in medulloblastoma (MBL) patients and only few cases of subcutaneous localizations have been described. ENM indicate an aggressive disease associated with a worse prog...

    Angela Mastronuzzi, Evelina Miele, Agnese Po, Manila Antonelli in BMC Cancer (2014)

  3. Article

    Open Access

    BRAF mutant colorectal cancer: ErbB2 expression levels as predictive factor for the response to combined BRAF/ErbB inhibitors

    Colorectal cancer (CRC) is a heterogeneous disease with a complex biology and a wide number of altered genes such as BRAF, KRAS and PIK3CA. Advances with new-targeted therapies have been achieved and available...

    Evelina Miele, Luana Abballe, Gian Paolo Spinelli, Zein Mersini Besharat in BMC Cancer (2020)